December 7, 20234Caja de Compensación de Asignación Familiar Los Andes’ US$145 Million Credit Facility
December 5, 20234Wilmar Group’s Divestment of its Stake in Cosumar to a Consortium of Moroccan Investors
December 1, 20234The Sovereign Fund of Egypt’s Partnership Agreement with Tanweer for Educational Services
June 21, 20234Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture
June 19, 20234The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.
May 30, 20234Presumption of “Tax Inversion”: The Italian Supreme Court Clarifues That “Mediated” Control Is Not Relevant
Homepage North America North America Legal Chronicle Merck’s $11.5 Billion Acquisition of Acceleron Pharma Merck’s $11.5 Billion Acquisition of Acceleron Pharma October 4, 2021October 5, 2021 Laura Testa Tagged: Acceleron Pharma Aileen Kim Blake Liggio Centerview Partners Christopher Comeau Credit Suisse Fahreen Velji Goldman Sachs & Co. Goodwin Procter Graham Robinson J.P. Morgan Securities LLC James Matarese Kyle Higley Leo Arnaboldi Marc Rubenstein Marie Gibson megadeals Michael McFalls Michael Tentilucci Rami Mosrie Renata Ferrari Ropes & Gray Skadden Arps Slate Meager & Flom Stuart Cable Covington & Burling and Gibson, Dunn & Crutcher advised Merck, while Ropes & Gray advised Acceleron. Skadden, Arps, Slate, Meagher & Flom represented Centerview Partners LLC… This content is for Standard 1 Year members only.Login Join Now
